Synergistic Effects of Monolaurin, Thymosin Alpha-1, KPV, SS-31, MOTS-c, Zinc, Vitamin D3, B12, Folate, Selenium, Magnesium Glycinate, and DGL on Epstein-Barr Virus Reversal in a Murine Gammaherpesvirus 68 (MHV-68) Model.docx
physician_protocol · expert_opinion · status: needs_provider_review
Metadata
Summary (generated — provider review required)
Synergistic Effects of Monolaurin, Thymosin Alpha-1, KPV, SS-31, MOTS-c, Zinc, Vitamin D3, B12, Folate, Selenium, Magnesium Glycinate, and DGL on Epstein-Barr Virus Reversal in a Murine Gammaherpesvirus 68 (MHV-68) Model Abstract - Read the highlighted areas for the solutions !!!! This study evaluates the combined administration of Monolaurin (1000 mg three times a day orally with food), Thymosin Alpha-1 (1 mg three times a week subcutaneously), KPV (400 mcg twice per day subcutaneously), SS-31 (1 mg daily subcutaneously), MOTS-c (1 mg daily subcutaneously), Zinc (30 mg daily orally), Vitamin D3 (10,000 IU daily orally), B12 (full daily oral dose), Folate (full daily oral dose), Selenium (200 mcg daily orally), Magnesium Glycinate (400 mg daily orally), and DGL (400 mg before meals orally) on Epstein-Barr virus (EBV) reversal in a murine gammaherpesvirus 68 (MHV-68) model in adult male C57BL/6 mice over a 12-week period. Primary outcomes included viral load reduction (qPCR for MHV-68 DNA in spleen, lung, and blood) and antibody response (VCA IgM/IgG and EBNA IgG ELISA).
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (7) · phenotypes (2)
evidence_reference, dosing_reference, mechanism, safety_reference, monitoring_reference
Phenotypes: immune_dysregulation, mitochondrial_dysfunction
Evidence claims (28) · review items (18)
dosing · pending
This study evaluates the combined administration of Monolaurin (1000 mg three times a day orally with food), Thymosin Alpha-1 (1 mg three times a week subcutaneously), KPV (400 mcg twice per day subcutaneously), SS-31 (1 mg daily subcutaneously), MOTS-c (1 mg daily subcutaneously), Zinc (30 mg daily orally), Vitamin D3 (10,000 IU daily orally), B12 (full daily oral dose), Folate (full daily oral dose), Selenium (200 mcg daily orally), Magnesium Glycinate (400 mg daily orally), and DGL (400 mg before meals orally) on Epstein-Barr virus (EBV) reversal in a murine gammaherpesvirus 68 (MHV-68) model in adult male C57BL/6 mice over a 12-week period.
outcome · pending
Primary outcomes included viral load reduction (qPCR for MHV-68 DNA in spleen, lung, and blood) and antibody response (VCA IgM/IgG and EBNA IgG ELISA).
mechanism · pending
Secondary measures encompassed systemic inflammation (TNF-α/IL-6 ELISA), oxidative stress (ROS/MDA levels), mitochondrial ATP production (luminescence assay), immune modulation (splenic CD4+/CD8+ ratio via flow cytometry), and physical performance (grip strength).
outcome · pending
The combination reduced viral load by 70%, normalized VCA/EBNA antibody titers, decreased inflammation by 55%, reduced oxidative stress by 50%, enhanced ATP production by 45%, normalized immune ratios, and improved grip strength by 40% compared to infected controls.
safety · pending
No adverse effects were observed.
mechanism · pending
immunomodulatory, anti-inflammatory, and mitochondrial mechanisms.
safety · pending
GET EVERYTHING HERE ⬇️ https://elitebiogenix.com/ Work with Dr Trevor Bachmeyer apply@unlockthecard.com Introduction Epstein-Barr virus (EBV) is a gammaherpesvirus that establishes lifelong latency, causing persistent inflammation, oxidative stress, mitochondrial dysfunction, and immune dysregulation, often leading to chronic symptoms and increased risk of autoimmune and oncologic complications.
outcome · pending
SS-31 protects mitochondria and reduces ROS in viral stress models.
regulatory · pending
Materials and Methods Ethical Statement Approved by the Institutional Animal Care and Use Committee (IACUC) under protocol #2026-MUR-056, complying with the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) and EU Directive 2010/63/EU.
dosing · pending
GET EVERYTHING HERE ⬇️ https://elitebiogenix.com/ Work with Dr Trevor Bachmeyer apply@unlockthecard.com Compound Administration Compounds (>98% purity, certified suppliers) administered using exact specified dosages without alteration: Monolaurin: 1000 mg three times a day orally with food (scaled gavage).
dosing · pending
Thymosin Alpha-1: 1 mg three times a week subcutaneously (Mon/Wed/Fri, 8 AM).
dosing · pending
KPV: 400 mcg twice per day subcutaneously (8 AM/PM).
dosing · pending
SS-31: 1 mg daily subcutaneously (8 AM).
dosing · pending
MOTS-c: 1 mg daily subcutaneously (8 AM).
dosing · pending
Zinc: 30 mg daily orally (8 AM).
dosing · pending
Vitamin D3: 10,000 IU daily orally (8 AM).
dosing · pending
B12: full daily oral dose (8 AM).
dosing · pending
Folate: full daily oral dose (8 AM).
dosing · pending
Selenium: 200 mcg daily orally (8 AM).
dosing · pending
Magnesium Glycinate: 400 mg daily orally (evening).
dosing · pending
DGL: 400 mg before meals orally.
outcome · pending
Pre-Treatment and Outcome Testing
outcome · pending
Outcome Measures: Viral load (qPCR for MHV-68 DNA in spleen/lung/blood) endpoint, antibody response (VCA IgM/IgG and EBNA IgG ELISA), inflammation (TNF-α/IL-6 ELISA), oxidative stress (ROS/MDA), mitochondrial ATP (luminescence assay), immune modulation (CD4+/CD8+ ratio), physical performance (grip strength).
safety · pending
GET EVERYTHING HERE ⬇️ https://elitebiogenix.com/ Work with Dr Trevor Bachmeyer apply@unlockthecard.com Results Survival 100%; no toxicity.
outcome · pending
Group Viral Load (Log Copies/g) VCA IgG Reduction (%) Control 6.5 ± 0.4 0 Individual (Avg) 4.0 ± 0.5 40 ± 5 Combination 2.0 ± 0.3 70 ± 6 Inflammation and Oxidative Stress TNF-α/IL-6 -55% (p<0.001).
mechanism · pending
Mitochondrial ATP Production and Immune Modulation ATP +45% (p<0.001).
monitoring · pending
GET EVERYTHING HERE ⬇️ https://elitebiogenix.com/ Work with Dr Trevor Bachmeyer apply@unlockthecard.com Monitoring Daily: Symptom log.
safety · pending
Safety Mild reactions possible (injection sites).
Extracted chunks (7)
901 approx tokens across 7 chunks.